✦ LIBER ✦

P174 Longitudinal clinical and electroneurographic assessment of asymptomatic HIV seropositive subjects

✍ Scribed by P. Gambaro; M. Osio; E. Dezuanni; F. Tripaldi; M.G. Bellotti; P. Meraviglia; A. Mangoni

Book ID: 115871639
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 134 KB
Volume: 99
Category: Article
ISSN: 0013-4694
DOI: 10.1016/0013-4694(96)88300-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PS-40-6 Longitudinal evaluation of multi

PS-40-6 Longitudinal evaluation of multimodal evoked potentials in asymptomatic HIV seropositive subjects

✍ Paola Gambaro; Michela Mauri; Maurizio Osio; Pierluigi Bertora; Paola Meraviglia 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Dose proportionality of stavudine in hiv

Dose proportionality of stavudine in hiv seropositive asymptomatic subjects: Application to bioequivalence assessment of various capsule formulations

✍ Sanjeev Kaul; Vanaja Mummaneni; Rashmi H. Barbhaiya 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 658 KB

The dose proportionality and bioequivalence of the capsule formulations used in clinical trials and the proposed commercial formulations of stavudine were assessed in an openlabel, single-dose, randomized four-way crossover study in 16 asymptomatic HIVinfected males. One capsule of stavudine (5, 10,

Longitudinal study of EEG and evoked pot

Longitudinal study of EEG and evoked potentials in neurologically asymptomatic HIV infected subjects

✍ Bahman Jabbari; Michael Coats; Andres Salazar; Alex Martin; Barbara Scherokman; 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 666 KB

Effects of smoking and clinical status o

Effects of smoking and clinical status on lung function in human immunodeficiency virus (HIV)-seropositive subjects

✍ R.N. McCabe; J. Baron; R. Griffin; M. Omogbehin; P.D. Snashall; W.A. Seed 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 842 KB

Clinical outcome after 4 years follow-up

Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART

✍ Emanuele Nicastri; Antonio Chiesi; Claudio Angeletti; Loredana Sarmati; Lucia Pa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

## Abstract The duration of the clinical, virologic, and immunologic response to HAART, is not well defined. In this observational multi‐center study 2,143 patients were enrolled classified according to virologic suppression (<500 cp/ml) and immune recovery (>100 CD4+ cells/μl from baseline) at mon

Sequential ascending multiple-dose safet

Sequential ascending multiple-dose safety and pharmacokinetic study of oral lobucavir (BMS-180194) in asymptomatic volunteers seropositive for HIV and CMV: BG Petty, M Wachsman, MC Jordan, H Burgee, D DeHertogh, D Collins, RS Summerill, DA Jabs, JP Dunn, N Hellmann, B Kringstad, C Fletcher, L Smaldone, PS Lietman, MB Stewart. Division of Clinical Pharmacology, The Johns Hopkins University School of Medicine, Baltimore, MD; University of Minnesota, Minneapolis, MN; and Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ and Wallingford, CT, USA

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 72 KB